☆ 4.6 Article

PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial

ECLINICALMEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial

Mahamadou S. Sissoko et al.

Summary: A clinical trial was conducted in Mali to evaluate the safety, immunogenicity, and protective efficacy of the PfSPZ Vaccine in preventing malaria infection. The study found that the three-dose regimen of the vaccine was safe, well tolerated, and conferred 51% vaccine efficacy against natural P falciparum transmission.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Multidisciplinary Sciences

Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa

Joana C. Silva et al.

Summary: The study shows that controlled human malaria infection with a Brazilian parasite highly divergent from vaccine and West African field strains can provide estimates of vaccine efficacy in Mali, and could replace field testing, streamlining vaccine development.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Multidisciplinary Sciences

Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial

Zita Sulyok et al.

Summary: The study reports the results of a trial on a simplified PfSPZ-CVac immunization regimen, demonstrating its high efficacy, safety, good tolerability, and high immunogenicity in malaria-naive participants.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity

Agnes Mwakingwe-Omari et al.

Summary: Increased vaccine efficacy against malaria can be achieved through higher vaccine dosage and specific chemoprophylaxis vaccination regimens, providing protection against both homologous and heterologous parasite strains. This enhanced protection is associated with V delta 2 gamma delta T cell and antibody responses.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial

Martina Oneko et al.

Summary: A trial of Plasmodium falciparum vaccine in infants in a high-transmission malaria setting in western Kenya showed good safety and tolerability, but no significant protection against P. falciparum infection at 6 months. There was a dose-dependent increase in antibody responses, while T cell responses were undetectable in all dose groups.

NATURE MEDICINE (2021)

Add to Collection

Article Microbiology

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

Sean C. Murphy et al.

Summary: The study evaluated different dosing schedules of PfSPZ-CVac vaccine and found that a higher dose given with a shorter interval achieved better vaccine efficacy, while administering the vaccine during blood-stage parasitemia resulted in almost no efficacy. This suggests that blood-stage infections may impair the protective responses to malaria.

PLOS PATHOGENS (2021)

Add to Collection

Article Immunology

Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults

Said A. Jongo et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants

Said A. Jongo et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)

Add to Collection

Article Public, Environmental & Occupational Health

Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults

Said A. Jongo et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)

Add to Collection

Article Infectious Diseases

Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial

Mahamadou S. Sissoko et al.

LANCET INFECTIOUS DISEASES (2017)

Add to Collection

Article Multidisciplinary Sciences

Sterile protection against human malaria by chemoattenuated PfSPZ vaccine

Benjamin Mordmueller et al.

NATURE (2017)

Add to Collection

Article Multidisciplinary Sciences

High Plasmodium falciparum longitudinal prevalence is associated with high multiclonality and reduced clinical malaria risk in a seasonal transmission area of Mali

Yaw Adomako-Ankomah et al.

PLOS ONE (2017)

Add to Collection

Article Immunology

Loss of Humoral and Cellular Immunity to Invasive Nontyphoidal Salmonella during Current or Convalescent Plasmodium falciparum Infection in Malawian Children

Tonney S. Nyirenda et al.

CLINICAL AND VACCINE IMMUNOLOGY (2017)

Add to Collection

Article Immunology

Asymptomatic Multiclonal Plasmodium falciparum Infections Carried Through the Dry Season Predict Protection Against Subsequent Clinical Malaria

Klara Sonden et al.

JOURNAL OF INFECTIOUS DISEASES (2015)

Add to Collection

Article Infectious Diseases

Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres

Benjamin Mordmueller et al.

MALARIA JOURNAL (2015)

Add to Collection

Article Immunology

Vaccines Against Malaria

Amed Ouattara et al.

CLINICAL INFECTIOUS DISEASES (2015)

Add to Collection

Article Immunology

Cytotoxic Markers Associate With Protection Against Malaria in Human Volunteers Immunized With Plasmodium falciparum Sporozoites

Else M. Bijker et al.

JOURNAL OF INFECTIOUS DISEASES (2014)

Add to Collection

Article Multidisciplinary Sciences

Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

Robert A. Seder et al.

SCIENCE (2013)

Add to Collection

Article Medicine, General & Internal

Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study

Meta Roestenberg et al.

LANCET (2011)

Add to Collection

Article Multidisciplinary Sciences

Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity

J. E. Epstein et al.

SCIENCE (2011)

Add to Collection

Article Multidisciplinary Sciences

Plasmodium falciparum Malaria Challenge by the Bite of Aseptic Anopheles stephensi Mosquitoes: Results of a Randomized Infectivity Trial

Kirsten E. Lyke et al.

PLOS ONE (2010)

Add to Collection

Review Microbiology

Acquired Immunity to Malaria

Denise L. Doolan et al.

CLINICAL MICROBIOLOGY REVIEWS (2009)

Add to Collection

Article Medicine, General & Internal

Protection against a Malaria Challenge by Sporozoite Inoculation.

Meta Roestenberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Add to Collection

Article Immunology

Malaria blood stage suppression of liver stage immunity by dendritic cells

C Ocaña-Morgner et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2003)

Add to Collection

Article Immunology

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

SL Hoffman et al.

JOURNAL OF INFECTIOUS DISEASES (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.